Proposal: Genetic Biomarkers and Bioactive Compounds (from Plants, Bacteria, and Fungi): Enhancing Diagnostic Methods with Innovative Solutions in Healthcare Settings Related to the Growing Enhance Antimicrobial Resistance
Proposed Implementation: 2025 to 2029
Call: HORIZON-HLTH-2024-DISEASE-09 – Partnerships in Health 2024
Topic: HORIZON-HLTH-2024-DISEASE-09-01
Type of Action: HORIZON-COFUND – HORIZON Programme Cofund Actions
Proposed Budget: 36 862 500,00€
Keywords: Antimicrobial resistance, Antimicrobials, Bacteria, Fungi, Health determinants, Pathogen agents, Genetic biomarkers, bioactive compounds, diagnostics
Objective: This project aims to enhance antimicrobial resistance diagnostic methods by integrating genetic biomarkers and bioactive compounds derived from plants, bacteria, and fungi. The primary objectives include advancing diagnostic precision through the identification and validation of resistance genes, utilizing bioactive compounds to improve diagnostic assays, and developing novel diagnostic tools for antimicrobial resistance detection. These solutions will be implemented in both clinical and health settings to enable proactive monitoring and timely interventions.
To achieve these objectives, the project will develop new diagnostic assays, prototype innovative biosensors, and conduct clinical trials to validate the efficacy of these methods in real-world scenarios. The training of healthcare professionals and the creation of educational resources will further support the integration of these solutions into clinical practice. The project will also focus on ensuring the cost-effectiveness and scalability of these innovations, aligning with public health strategies for antimicrobial resistance management.
This project aligns with the work programme by addressing the need for improved diagnostic tools to combat antimicrobial resistance. It contributes to the scientific community by advancing research on biomarkers and bioactive compounds, offering practical solutions to enhance diagnostic accuracy and support personalized treatment strategies.
Partners:
- İzmir Project Agency Association
- Health Citizens – European Institute
- Azerbaijan Ministry of Science and Education Institute of Microbiology
- Baku State University
- The Stephan Angeloff Institute of Microbiology
- Fundació Hitt
- Istanbul Nisantasi University
- Altınbaş Üniversitesi
- İzmir Demokrasi Üniversitesi
- University of Zagreb
- University of Oradea